Chordate Medical Holding AB (publ) (STO:CMH)

Market Cap	222.86K -98.3%
Revenue (ttm)	1.25M -60.5%
Net Income	-25.16M
EPS	-11.68
Shares Out	2.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	258,170
Average Volume	88,026
Open	0.1595
Previous Close	0.1600
Day's Range	0.0800 - 0.2480
52-Week Range	0.0800 - 16.0000
Beta	1.82
RSI	32.39
Earnings Date	Mar 27, 2026

About STO:CMH

Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. It offers Ozilia, a neuromodulation and medication-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 3
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: CMH

Financial Performance

In 2024, STO:CMH's revenue was 2.44 million, an increase of 39.85% compared to the previous year's 1.75 million. Losses were -27.25 million, -6.62% less than in 2023.